Adipose Tissue Thickness In Patients Research Articles

Association of FoxP3<sup>+</sup> T regulatory lymphocytes with epicardial adipose tissue thickness in patients with coronary heart disease

Background. Increase ofthe epicardial adipose tissue (EAT) thickness isassociated with development of inflammation and cardiovascular complications, however, there is no data on the relationship between EAT thickening and the number of immunosuppressive regulatory T lymphocytes.The aim. To study the number of circulating T regulatory lymphocytes and nuclear translocation ofthe FoxP3 transcription factor in patients with stable coronary heart disease (CHD) depending on the epicardial adipose tissue thickness.Materials and methods. We examined 30 patients with chronic stable CHD. The EAT thickness was measured by echocardiography. Patients were divided into groups depending on the presence and absence of EAT thickening above 5 mm (groups 1 and 2, respectively). Imaging flow cytometry was used to determine the number of T regulatory lymphocytes and the level of FoxP3 nuclear translocation. The concentration of cytokines and high sensitivity C-reactive protein (hsCRP) was determined using enzyme-linked immunosorbent assay in blood serum.Results. Anthropometric indicators of obesity and the severity of atherosclerosis were comparable between groups. In group 2, there was an increase in low-density lipoprotein cholesterol concentration (p = 0.043), ratio of low-density lipoprotein cholesterol tohigh-density lipoprotein cholesterol (p = 0.017) and the concentration ofhsCRP (p = 0.044) andIL-1β (p = 0.005), adecrease in the number and relative count of Tregulatory lymphocytes (p = 0.020 andp = 0.026, respectively), aswellas thenumber of cells withFoxP3 nuclear translocation (p = 0.018) compared togroup1. According tomultiple logistic regression, the concentration ofhsCRP, IL-1β and T regulatory lymphocytes relative count in total were the predictors of EAT thickening (accuracy 80 %; sensitivity 75 %; specificity 84,6 %; AUC = 0.89).Conclusions. Thickening of epicardial adipose tissue inpatients withcoronary heart disease is associated with a decrease in the number of T regulatory lymphocytes andFoxP3 nuclear translocation inthem in presence of comparable anthropometric parameters of obesity and the severity of coronary atherosclerosis.

Study of Epicardial adipose tissue thickness in patients with Diabetes Mellitus and its correlation with severity of Coronary artery disease.

Study of Epicardial adipose tissue thickness in patients with Diabetes Mellitus and its correlation with severity of Coronary artery disease.

LİPÖDEMDE SUBKÜTAN YAĞ DOKUSU KALINLIĞI İLE ADİPOKİNLER ARASINDAKİ İLİŞKİ

Giriş ve Amaç: Adipokinler ve disfonksiyonel yağ dokusu arasındaki ilişkide subkutan yağ dokusundan ziyade viseral yağ dokusundaki değişikliklerin rolüne dikkat çekilmiştir. Özellikle cilt altı yağ dokusunun etkilendiği lipödemde adipokinler hakkında bilgi yetersizdir. Bu çalışmada lipödemli hastalarda adiponektin, ghrelin, resistin ve visfatin düzeylerinin ve bunların yağ doku kalınlığı ile ilişkisinin araştırılması amaçlandı. Bu amaçla cilt altı yağ dokusu kalınlığı ultrasonografi ile objektif olarak değerlendirildi.
 Gereç ve Yöntemler: Lipödem tanısı almış toplam 19 kadın hasta ve yaş farkı olmayan 15 sağlıklı kadın çalışmaya dahil edildi. Deri ve deri altı yağ dokusu kalınlıkları ultrasonografik olarak ölçüldü. Tüm deneklerin serum adiponektin, ghrein, resistin ve visfatin seviyeleri sandviç ELISA protokolü kullanılarak ölçüldü.
 Bulgular: Lipödemli hastalarda, uyluk ve baldırda subkutan subkutan doku kalınlığı ve toplam deri-subkutan kalınlığı kontrollere kıyasla, uyluktaki deri kalınlığı dışında önemli ölçüde arttı (P0.05). Lipödemli hastalarda ve kontrollerde ultrason ile adiponektin, ghrelin, resistin ve visfatin ile deri, deri altı ve toplam kalınlık ölçümleri arasında anlamlı bir ilişki bulunmadı (P>0.05). İstatistiksel olarak anlamlı olmasa da detaylı incelendiğinde adipokinler ve ultrason ölçümleri arasındaki ilişkide gruplar arasında pozitif veya negatif korelasyonlar gözlendi.
 Sonuç: Bulgularımıza göre, serum adipokin düzeyleri ile deri altı yağ dokusu kalınlığı arasında anlamlı bir ilişki bulunmamakla birlikte, tamamen ilgisiz oldukları tartışmalıdır. Daha geniş serilerde yapılacak çalışmalar adipokinlerin cilt altı doku kalınlığı ile ilişkisine ve ultrasonografinin önemine ışık tutacaktır.

Assessment of Skeletal Muscle Oxygenation during Exercise in Patients with Peripheral Artery Disease Using Near Infrared Spectroscopy: Impact of Skin Color and Adipose Tissue Thickness

IntroductionNear infrared spectroscopy (NIRS) is a potentially valuable tool to examine disease severity and the effects of therapeutic interventions on microvascular leg oxygenation in patients with peripheral artery disease (PAD). However, multiple factors can confound the interpretation of NIRS signals and therefore limit its clinical applicability, including adipose tissue thickness (ATT) and skin melanin content. We tested the hypothesis that the changes in the concentration of oxygenated [oxy‐Hb+Mb] and deoxygenated [deoxy‐Hb+Mb] hemoglobin + myoglobin would be reduced in the calf of black PAD patients during exercise when compared to white patients. Similarly, we hypothesized that patients with a thicker calf ATT would exhibit a lower change in oxy[Hb+Mb] and deoxy[Hb+Mb] during exercise relative to patients with low ATT.MethodsTwenty‐four participants with a history of exertional calf pain (18 males, 6 females, 67±7 years; ankle‐brachial index: 0.6±0.1) were asked to complete two graded tests on the treadmill. The protocol consisted of a constant walking speed of 2 mph and progressive increases in grade of 2% every 2 min. The NIRS device was secured to the skin over the medial gastrocnemius muscle of the most symptomatic leg. Oxy[Hb+Mb] and deoxy[Hb+Mb] were measured continuously at rest and during exercise. The final 20‐s averages of stages 1, 2 and peak exercise were utilized for analysis. Magnetic resonance imaging of the calf was used to measure ATT. The average ATT among all individuals (7±3 mm) was used to divide participants into ‘low’ (n=12) or ‘high’ (n=12) ATT groups. A three‐way repeated measures analysis of variance was used to evaluate the effects of skin color, ATT, and stage of the treadmill test (i.e. stage 1, stage 2, peak walking time) on the changes from baseline in calf oxy[Hb+Mb] and deoxy[Hb+Mb].ResultsSeven participants were black and the remaining 17 were white. The average ATT at the medial gastrocnemius site was 4±1 mm in the low ATT group and 9±2 mm in the high ATT group. A significant interaction was observed between skin color, ATT, and exercise stage for the change from baseline in oxy[Hb+Mb] (p=0.049). Post‐hoc testing revealed that among white participants, the change in oxy[Hb+Mb] during exercise was significantly lower in the high ATT group when compared to the low ATT group (p=0.039). Among black participants, the change in calf oxy[Hb+Mb] was similar between high and low ATT (p=0.57). There was a trend for a main effect of ATT on the changes in deoxy[Hb+Mb] during exercise (p=0.1), but the main effects of skin color (p=0.2) and the interaction between skin color, ATT, and exercise stage (p=0.5) were not significant.ConclusionsIn conclusion, the changes in NIRS‐derived calf oxy[Hb+Mb] during exercise are impacted by both skin color and ATT in patients with symptomatic PAD.

Evaluation of Atrial Conduction Times and Epicardial Adipose Tissue Thickness in Patients with Ankylosing Spondylitis

Evaluation of Atrial Conduction Times and Epicardial Adipose Tissue Thickness in Patients with Ankylosing Spondylitis

Epicardial adipose tissue thickness in patients with urolithiasis

Aim: We aimed to assess the relationship between urinary stone disease which is accepted as a component of metabolic syndrome and epicardial adipose tissue (EAT) thickness. Methods: The study included 45 patients and 39 healthy controls. EAT thickness was measured by echocardiography in all subjects.

Effect of Cardiac Exercise Rehabilitation on Epicardial Adipose Tissue Thickness in Patients with Coronary Heart Disease

Effect of Cardiac Exercise Rehabilitation on Epicardial Adipose Tissue Thickness in Patients with Coronary Heart Disease

Echocardiographic measurement of epicardial adipose tissue thickness in patients with microvascular angina.

IntroductionImpaired coronary microcirculation, inflammation, and endothelial dysfunction were reported etiological factors for microvascular angina (MVA). Recently, increased epicardial adipose tissue (EAT) thickness has been associated with hypertension, metabolic syndrome, and coronary artery disease in general population. In this study, we aimed to evaluate the EAT thickness in patients with MVA.MethodsThis study enrolled 200 patients (83 males; mean age: 55.4 ± 8.2 years) who have been diagnosed with MVA and 200 controls (89 males; mean age: 54.4 ± 8.5 years). All patients underwent transthoracic echocardiography, and EAT thickness was measured from a parasternal long-axis view as the hypoechoic space on the right ventricular free wall.ResultsThe mean EAT thickness was significantly higher in MVA patients than the controls (5.5 ± 1.1 vs. 4.9 ± 0.7 mm; p < 0.001). Multiple logistic regression analysis showed that increased EAT thickness was an independent predictor of MVA (OR = 1.183, 95% CI = 1.063–1.489; p = 0.023). In receiver operating characteristic curve analyses, EAT thickness above 5.3 mm predicted MVA with a sentivity of 68% and a specificity of 63% (AUC = 0.711, 95% CI = 0.659–0.762; p < 0.001).ConclusionsThe EAT thickness was observed significantly higher in MVA patients as compared to controls. Increased EAT thickness may be associated with mechanisms that play a major role in the pathogenesis of MVA.

Pro-atherogenic mediators and subclinical atherogenesis are related to epicardial adipose tissue thickness in patients with cardiovascular risk.

ObjectiveTo evaluate the relationship between pro-atherogenic biomarkers and epicardial adipose tissue (EAT) thickness in patients with cardiovascular risk factors.MethodsPlasma nitric oxide (NO), soluble intercellular adhesion molecule-1 and malondialdehyde (MDA) levels, EAT thickness, flow-mediated dilation (FMD) and carotid intima media thickness (CIMT) were determined in patients aged >18 years who were referred for echocardiography for heart ischemia or non-ischemic diseases. Cardiovascular risk factors (Framingham score [FS] ≥ 20) were weighted.ResultsHypertension, dyslipidaemia and type 2 diabetes mellitus were prevalent (≥55% of 40 patients). Patients with FS ≥ 20 (n = 21) showed significantly higher EAT and CIMT values. Globally, MDA, CIMT, age, waist circumference, high-density lipoprotein cholesterol (HDL-C) and FS were associated with EAT thickness. EAT was significantly associated with NO in patients with FS ≥ 20. Significant differences in EAT thickness were found between patients stratified by NO value, FMD, age, smoking status, dyslipidaemia, type 2 diabetes mellitus and FS. An EAT-associated atherogenic risk (CIMT ≥ 1 mm) model was statistically significant when MDA and type 2 diabetes mellitus were included.ConclusionEAT thickness was associated with MDA, CIMT, age, waist circumference, HDL-C and FS globally, but with NO only in patients with FS≥20. EAT may be used to identify vascular damage stage, possibly influenced by MDA and type 2 diabetes mellitus.

Assessment of epicardial adipose tissue thickness in patients with resistant hypertension.

Recent studies have shown that epicardial adipose tissue (EAT) thickness is increased in patients with hypertension. In this study, we aimed to investigate the relation of EAT thickness with resistant hypertension (RHT). Study participants (n=150) were classified into three groups according to their office and ambulatory blood pressure measurements: RHT (n=50), controlled hypertension (CHT, n=50), and normotension (NT, n=50). All patients underwent a transthoracic echocardiographic examination to measure EAT thickness. Clinical and biochemical characteristics of the groups were similar, except the CRP level, which was significantly increased in hypertensive patients compared with patients with NT (P<0.001). EAT thickness differed significantly between groups (P<0.001). The highest values were obtained in the RHT group (4.64±1.24 cm), followed by the CHT (3.3±0.82 cm) and NT (2.6±0.76 cm) groups. Multivariate analysis indicated age, physical activity level, and EAT thickness as independent predictors of RHT. The optimal cut-off value of EAT thickness for detection of RHT was found to be 3.42 cm, with a sensitivity and specificity of 82 and 77%, respectively (AUC=0.87, 95% confidence interval 0.81-0.92, P<0.000). EAT can be effective on blood pressure by several mechanisms. In this study, for the first time in the literature, the association of EAT with RHT is reported.

Epicardial Adipose Tissue Thickness in Patients With Subclinical Hypothyroidism and the Relationship Thereof With Visceral Adipose Tissue Thickness.

BackgroundSubclinical hypothyroidism (SH) is associated with cardiovascular metabolic syndromes, especially dislipidemia and abdominal obesity. Visceral abdominal adipose tissue (VAAT) and epicardial adipose tissue (EAT) have the same ontogenic origin and produce many proinflammatory and proatherogenic cytokines. We evaluated EAT and VAAT thickness in patients with SH.MethodsForty-one patients with SH and 35 controls were included in the study. Demographical and anthropometric features of both patients and controls were recorded. Thyroid and metabolic parameters were measured. EAT was measured using 2D-transthoracic echocardiography.ResultsThe age and gender distributions were similar in the two groups (P = 0.998 and P = 0.121, respectively). Body mass index (BMI), fat mass, waist circumference (WC), hip circumference (HC), the WC/HC ratio, and the thicknesses of VAAT and abdominal subcutaneous adipose tissue were higher in the case group than the control group (all P values < 0.01). However, both groups had similar EAT thickness (P = 0.532), which was positively correlated with BMI, fat mass, WC, HC, VAAT thickness, abdominal subcutaneous adipose tissue thickness, and serum triglyceride (TG) level (all P values < 0.01). We found no correlation between EAT thickness and thyroid-stimulating hormone (TSH) level, free thyroxine (FT4) level, or low-density lipoprotein-cholesterol (LDL-C) level, and anti-TPO level (all P values > 0.05). We found no difference between the two groups in fasting plasma glucose (FPG) level (P = 0.780), but the levels of LDL-C and TG differed significantly (P = 0.002 and P = 0.026, respectively). The serum TSH level was higher and the FT4 level was lower in the case than the control group (both P values <0.01).ConclusionIncreased abdominal adipose tissue thickness in patients with SH is associated with atherosclerosis. To detemine the risk of atherosclerosis in such patients, EAT measurements are valuable; such assessment is simple to perform.

GW25-e4322 Epicardial adipose tissue thickness in patients with metabolic syndrome: A Systematic Review and Meta-analysis

Many clinical imaging studies demonstrated a strong correlation between epicardial adipose tissue (EAT) and metabolic syndrome (MS) over the past decade. However, inconsistent results regarding this were reported in other studies. In our study we performed a meta-analysis to examine whether the

Evaluation of epicardial adipose tissue thickness in patients with overt hyperthyroidism

Evaluation of epicardial adipose tissue thickness in patients with overt hyperthyroidism

Epicardial adipose tissue thickness in patients with ankylosing spondylitis

The purpose of our study was to measure epicardial adipose tissue (EAT) thickness as a novel indicator of atherosclerosis and cardiovascular risk factor in ankylosing spondylitis (AS) patients and to show the relationship with clinical parameters and inflammatory markers. Forty AS patients (42.75 ± 12.43 years) and 40 healthy individuals with no cardiovascular risk factor as the control group (43.02 ± 14.78 years) were included in the study. Carotid intima-media thickness (CIMT) and EAT thickness were measured in AS patients and the control group. Total cholesterol, high-density lipoprotein (HDL) cholesterol, low-density lipoprotein (LDL) cholesterol, glucose, erythrocyte sedimentation rate, urea, and blood pressure were investigated in both groups. In addition, the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) were used to evaluate the association between clinical findings and CIMT and EAT in the patient group. CIMT and EAT thickness were higher in the AS patients compared to the control group. CIMT was 0.76 ± 0.19 and 0.57 ± 0.12 mm (p < 0.001) and EAT thickness was 4.35 ± 1.56 and 3.03 ± 0.94 mm (p < 0.001) in the AS and control groups, respectively. A correlation was determined between EAT thickness and CIMT. Triglyceride level, patient age, blood pressure, and duration of disease were correlated with both CIMT and EAT thickness. Increased CIMT and EAT thickness in AS patients compared to the control group shows a risk for subclinical atherosclerosis and cardiovascular disease.

Increased Epicardial Adipose Tissue Thickness in Patients with Behcet's Disease

Hakan Tasolar, Sevgi Tasolar, Duygu Kurtulus, Burak Altun, Adil Bayramo glu, Omur Otlu, Mehmet Balli, Mustafa Cetin, Nihal Altunisik, Yelda Kapicio glu, Hasan Pekdemir Adiyaman University Training and Research Hospital, Department of Cardiology, Adiyaman, Adiyaman University Training and Research Hospital, Department of Radiology, Adiyaman, Haydarpasa Numune Training and Research Hospital, Clinic of Physical Treatment and Rehabilitation, Istanbul, 18 Mart University, Faculty of Medicine, Department of Cardiology, Canakkale, Inonu University, Faculty of Medicine, Turgut Ozal Medical Center, Department of Cardiology, Malatya, Inonu University, Faculty of Medicine, Turgut Ozal Medical Center, Department of Dermatology, Malatya

ASSA13-02-23 Relationship of Thickness of Left Atrial Epicardial Adipose Tissue and Atrial Fibrillation

BackgroundObesity is an important risk factor for atrial fibrillation (AF). Epicardial adipose tissue in close anatomic proximity to cardiac structures and autonomic fibres, is a source of several inflammatory mediators...

Serum γ-Glutamyltransferase Levels Correlate With Epicardial Adipose Tissue Thickness in Patients With Coronary Artery Disease

Epicardial adipose tissue (EAT) is related to the presence of coronary artery disease (CAD). Increased γ-glutamyltransferase (GGT) activity is associated with atherosclerosis. We assessed the relationship between EAT and serum GGT activity in addition to cardiovascular risk factors in patients with stable anginal symptoms. Consecutive patients (n = 120) who underwent coronary angiography were included. Epicardial adipose tissue thickness was measured by echocardiography. Serum GGT activity was measured by enzymatic colorimetric assay. Epicardial adipose tissue thickness and serum GGT activity were higher in patients with CAD (n = 83). Patients with metabolic syndrome (n = 83) were found to have higher EAT thickness. Serum GGT activity was independently associated with EAT values. In conclusion, echocardiographic EAT was significantly higher in patients with CAD and serum GGT activity correlated with EAT thickness.

Evaluation of Skin and Subcutaneous Adipose Tissue Thickness for Optimal Insulin Injection

Patient’s skin and subcutaneous adipose tissue thicknesses are the primary criteria that determine the optimal insulin needle length in subcutaneous insulin treatment. The present study aims to measure skin thickness and subcutaneous adipose tissue thickness in patients with diabetes mellitus and to investigate the association of these measurements with waist circumference and body mass index. The study included 449 subjects (152 patients with DM and 297 healthy controls, mean age: 44.58 ± 14.25 year) aged 18 years or older. The primary endpoint was the time of comparison of skin thicknesses and subcutaneous adipose tissue thicknesses between patients with diabetes mellitus and healthy subjects and the secondary endpoint was the time of assessment of the relationship between skin and subcutaneous adipose tissue thicknesses and body mass index and waist circumference. Skin and subcutaneous adipose tissue thicknesses were measured by ultrasonography. Overall, average skin thickness values were 1.95 mm (1.05-3.92) for triceps, 2.35 mm (1.07-3.82) for anterior abdomen and 1.97 mm (1.12-3.12) for anterior thigh, while subcutaneous adipose tissue thicknesses were 6.42 mm (1.01-33.5) for triceps, 15.73 mm (1.04-39.3) for anterior abdomen and 7.92 mm (1.48-31.6) for anterior thigh. Triceps and anterior thigh skin thickness values were higher in the diabetes mellitus group compared to healthy controls (p<0.01 for both) while subcutaneous adipose tissue thicknesses were similar between the two groups. There was a positive correlation between body mass index and waist circumference and between skin and subcutaneous adipose tissue thicknesses (p<0.01 for both). The largest skin thickness measured in the present study was 3.92 mm, which supports the previous reports that short needle tips could be used safely in individuals with diabetes mellitus.